Pilot Trial Suggests Structured Support May Help Limit Weight Regain After GLP-1 Treatment

Post-GLP-1 weight regain could be mitigated by diet

Weight regain following GLP-1 use is one of the key issues that users of the drugs face; so much so that the food industry is scrambling to address it. A recent pilot study suggested that dietary interventions can lessen this weight regain.

Structured support may slow weight regain after stopping GLP-1 drugs

Glucagon-like peptide-1 (GLP-1) receptor agonists are effective treatments for obesity, but discontinuation is common due to cost, insurance coverage limitations, side effects, patient preference, and other factors-commonly leading to rapid weight regain.

Pilot trial suggests structured support may help limit weight regain after GLP-1 treatment

Glucagon-like peptide-1 (GLP-1) receptor agonists are effective treatments for obesity, but discontinuation is common due to cost, insurance coverage limitations, side effects, patient preference and other factors—and often leads to rapid weight regain. Results from a pilot randomized trial, published in Obesity Science & Practice, suggest that structured support may attenuate early weight gain after GLP-1 cessation.

After GLP-1 Drugs Stop, Simple Support May Slow the Pounds Coming Back

A pilot randomized trial found that a digital wellness app or medically tailored meals sharply reduced early weight regain after adults stopped GLP-1 obesity therapy.